Key Insights

Highlights

Treatment Research

2 treatments under study, led by This Study Assess Acceptability Of Autonomous Conversation As Part Of Cataract Surgery Follow Up

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown2

Clinical Trials (2)

Research Network

Common Treatments

  • This Study Assess Acceptability Of Autonomous Conversation As Part Of Cataract Surgery Follow Up1
  • Kind Of Trifocal Iol1

Active Sponsors

  • Enrique Ordiñaga-Monreal, OD, MSc1
  • Innovate UK1
  • Ufonia1
  • Buckinghamshire Healthcare NHS Trust1

Top Investigators

Related Conditions

  • Visual Acuity1
  • Astigmatism1
  • Iol1

Activity Timeline